Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Gsk Plc ADR
(NY:
GSK
)
40.80
-0.82 (-1.97%)
Official Closing Price
Updated: 4:10 PM EDT, Sep 20, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Gsk Plc ADR
< Previous
1
2
3
4
5
6
7
8
9
...
30
31
Next >
Flu Vaccine Results Give Moderna (MRNA) Stock a Shot in the Arm
September 13, 2023
Moderna released encouraging results for its late-stage trial of its flu vaccine. Now, MRNA stock is looking like more than a one-trick pony.
Via
InvestorPlace
Moderna Stock Has Been Beaten Up; Why The CFO Says Its Story Is 'Misunderstood'
September 13, 2023
Moderna unveiled promising results in flu on Wednesday, adding to its respiratory suite.
Via
Investor's Business Daily
FDA Panel Says Popular OTC Cold, Allergy Medicine Might Be Useless - Stocks To Watch
September 12, 2023
According to FDA panel experts who reviewed the latest research on the long-questioned phenylephrine, a drug ingredient used in several leading decongestants used by millions of Americans looking for...
Via
Benzinga
Exposures
Product Safety
3 Pharmaceutical Stocks That Are Too Cheap to Ignore
September 09, 2023
Viatris, GSK, and Organon are all trading at less than 7 times earnings.
Via
The Motley Fool
Vivek Ramaswamy's Parallels With Warren Buffett Run Deeper Than Wanting To Make Roivant The 'Berkshire Hathaway Of Drug Development'
September 04, 2023
Presidential hopeful Vivek Ramaswamy and Warren Buffett may share different political ideologies but they have at least a couple of things in common.
Via
Benzinga
Peering Into GSK's Recent Short Interest
August 29, 2023
Via
Benzinga
Looking Into GSK's Recent Short Interest
August 04, 2023
Via
Benzinga
A Look Into GSK Inc's Price Over Earnings
August 03, 2023
Via
Benzinga
7 Stocks Hedge Funds Are Loading Up On
September 03, 2023
Hedge funds and many other financial institutions are loading up on these names considered to be among top institutional stock picks.
Via
InvestorPlace
GSK To Invest $272M In New Vaccine Facility Near Brussels, Slated To Open In 2027
August 30, 2023
GSK Plc (NYSE: GSK) has made an investment of over €250 million ($272 million) in a vaccine facility located in Belgium.
Via
Benzinga
3 Growth Stocks to Ride the Coming Bull Market in Style
August 26, 2023
Bull markets always follow bear markets, and these three companies are growth stocks to buy for the next wave higher
Via
InvestorPlace
3 Sorry Pharma Stocks to Sell in August Before It’s Too Late
August 22, 2023
Factors in the marketplace caused these companies to underperform, making them some of the top pharma stocks to sell.
Via
InvestorPlace
FDA Greenlights Pfizer's RSV Vaccine: Moms Can Now Protect Babies Before Birth
August 22, 2023
Monday, the FDA approved Pfizer Inc's (NYSE: PFE) Abrysvo (Respiratory Syncytial Virus Vaccine), the company's bivalent RSV prefusion F (RSVpreF) vaccine, to prevent the infection in infants from birth...
Via
Benzinga
Exposures
Product Safety
Is GSK Stock Worth Buying Right Now?
July 29, 2023
GSK stock could be a bargain.
Via
The Motley Fool
A Look Into GSK's Debt
July 17, 2023
Via
Benzinga
Is GSK an Excellent Dividend Stock to Buy for Passive Income Investors?
August 14, 2023
GSK offers a robust dividend yield, but that's not the only thing to consider.
Via
The Motley Fool
3 Pharma Stocks to Sell in August Before They Crash and Burn
August 11, 2023
Stay far away from these pharma stocks that are suffering from declining sales and weak pipelines of future products.
Via
InvestorPlace
GSK, Pfizer Lock Horns Over Patent Fight Related To Respiratory Syncytial Virus Vaccine
August 02, 2023
GSK Plc (NYSE: GSK) has sued Pfizer Inc (NYSE: PFE) in Delaware court, alleging that Pfizer's respiratory syncytial virus (RSV) vaccine Abrysvo violates GSK's four patent rights in its RSV
Via
Benzinga
GSK's Jemperli Plus Chemo Combo Scores FDA Approval As First New Frontline Treatment For Certain Type Of Endometrial Cancer
August 01, 2023
The FDA approved GSK plc's (NYSE: GSK) Jemperli (dostarlimab) in combination with carboplatin and paclitaxel, followed by Jemperli as a single agent for primary advanced or recurrent endometrial cancer...
Via
Benzinga
If You Can Only Buy One Dividend Stock, It Better Be One of These 7 Names
July 30, 2023
Here are seven of the best dividend stocks to consider immediately. Better, each of these stocks have strong, stable businesses.
Via
InvestorPlace
3 Millionaire-Maker Biotech Stocks to Buy Before the Window Closes
July 30, 2023
Here are three millionaire maker drug stocks from companies whose drugs could make truly staggering profits.
Via
InvestorPlace
GSK Says 'Excellent' Q2 Performance Boosted By Vaccine & HIV Drug Sales, Raises 2023 Outlook
July 26, 2023
GSK plc (NYSE: GSK) reported Q2 FY23 sales of £7.18 billion ($8.97 billion), up 4% Y/Y on t
Via
Benzinga
Pharma Giant GSK Beats Second-Quarter Goals On Growth In Vaccines, General Medicines
July 26, 2023
Pharmaceutical giant GSK beat expectations for the second quarter and raised its forecast for the full year. GSK stock rose on the news.
Via
Investor's Business Daily
Tesla's India Move, Adidas Receives Orders For Massive Unsold Yeezy Inventory, Spotify Raises Subscription Prices: Today's Top Stories
July 24, 2023
Wall Street Journal
Via
Benzinga
GSK-Pfizer Backed HIV-Focused Unit ViiV Healthcare's Cabotegravir Injected Drug, Tablets Secure European Backing For Approval
July 24, 2023
ViiV Healthcare received a positive opinion from the European Medicines Agen
Via
Benzinga
The 3 Most Undervalued Pharma Stocks to Buy Now: July 2023
July 21, 2023
Trading below a 15 forward price-to-earnings, these undervalued pharma stocks offer opportunities in an overbought market.
Via
InvestorPlace
Why Shares of Vir Biotechnology Are Plunging Thursday
July 20, 2023
The company had disappointing trial news for one of its lead therapies.
Via
The Motley Fool
Intercept Pharma Gets Double Upgrade: Analyst Says OCA Combo Therapy Can Extend PBC Business
July 13, 2023
HC Wainwright has upgraded Intercept Pharmaceuticals Inc (NASDAQ: ICPT) to Buy from Sell, with a price target of
Via
Benzinga
7 Stocks That AI Says Will Make You a Millionaire by 2025
July 13, 2023
These seven millionaire-maker stocks are changing hands at deeply undervalued levels. As their growth re-accelerates, so will your portfolio.
Via
InvestorPlace
3 Healthcare Stocks With Healthy Dividends
July 13, 2023
These pharmaceutical companies all combine relatively high dividends with safe payout ratios.
Via
The Motley Fool
< Previous
1
2
3
4
5
6
7
8
9
...
30
31
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.